Abstract

Highlights

  • Vapor nanobubble (VNB) photoporation represents a promising physical technique for mRNA transfection of adherent and suspension cells.

  • A multitude of parameters related to the VNB photoporation procedure were optimized to enable efficient mRNA transfection.

  • VNB photoporation was found to yield five times more living, transfected Jurkat T cells as compared to electroporation, i.e., currently the standard nonviral transfection technique for T cells.

Efficient and safe cell engineering by transfection of nucleic acids remains one of the long-standing hurdles for fundamental biomedical research and many new therapeutic applications, such as CAR T cell-based therapies. mRNA has recently gained increasing attention as a more safe and versatile alternative tool over viral- or DNA transposon-based approaches for the generation of adoptive T cells. However, limitations associated with existing nonviral mRNA delivery approaches hamper progress on genetic engineering of these hard-to-transfect immune cells. In this study, we demonstrate that gold nanoparticle-mediated vapor nanobubble (VNB) photoporation is a promising upcoming physical transfection method capable of delivering mRNA in both adherent and suspension cells. Initial transfection experiments on HeLa cells showed the importance of transfection buffer and cargo concentration, while the technology was furthermore shown to be effective for mRNA delivery in Jurkat T cells with transfection efficiencies up to 45%. Importantly, compared to electroporation, which is the reference technology for nonviral transfection of T cells, a fivefold increase in the number of transfected viable Jurkat T cells was observed. Altogether, our results point toward the use of VNB photoporation as a more gentle and efficient technology for intracellular mRNA delivery in adherent and suspension cells, with promising potential for the future engineering of cells in therapeutic and fundamental research applications.

Details

Title
Intracellular Delivery of mRNA in Adherent and Suspension Cells by Vapor Nanobubble Photoporation
Author
Raes Laurens 1   VIAFID ORCID Logo  ; Stremersch Stephan 1   VIAFID ORCID Logo  ; Fraire, Juan C 2   VIAFID ORCID Logo  ; Brans Toon 1 ; Goetgeluk Glenn 3 ; De Munter Stijn 3   VIAFID ORCID Logo  ; Lien, Van Hoecke 4   VIAFID ORCID Logo  ; Verbeke Rein 1   VIAFID ORCID Logo  ; Van Hoeck Jelter 1 ; Xiong Ranhua 2   VIAFID ORCID Logo  ; Saelens Xavier 5   VIAFID ORCID Logo  ; Vandekerckhove Bart 3   VIAFID ORCID Logo  ; De Smedt Stefaan 1 ; Raemdonck Koen 1 ; Braeckmans, Kevin 1   VIAFID ORCID Logo 

 Ghent University, Laboratory of General Biochemistry & Physical Pharmacy, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798); Cancer Research Institute Ghent (CRIG), Ghent, Belgium (GRID:grid.5342.0) 
 Ghent University, Laboratory of General Biochemistry & Physical Pharmacy, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798) 
 Cancer Research Institute Ghent (CRIG), Ghent, Belgium (GRID:grid.5342.0); Ghent University, Department of Diagnostic Sciences, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798) 
 Cancer Research Institute Ghent (CRIG), Ghent, Belgium (GRID:grid.5342.0); VIB-UGent Center for Medical Biotechnology, Ghent, Belgium (GRID:grid.11486.3a) (ISNI:0000000104788040); Ghent University, Department of Biomedical Molecular Biology, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798) 
 VIB-UGent Center for Medical Biotechnology, Ghent, Belgium (GRID:grid.11486.3a) (ISNI:0000000104788040); Ghent University, Department of Biochemistry and Microbiology, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798) 
Publication year
2020
Publication date
Dec 2020
Publisher
Springer Nature B.V.
ISSN
23116706
e-ISSN
21505551
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2473332929
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.